|
14 Jul 2011 |
Seattle Genetics Announces Unanimous Recommendations from FDA Advisory Committee in Favor of Accelerated Approval of ADCETRIS for Post-Transplant Relapsed Hodgkin Lymphoma and Relapsed or Refractory Systemic ALCL
|
|
14 Jul 2011 |
YERVOY (ipilimumab) Approved for the Treatment of Previously-Treated Advanced Melanoma in the EU
|
|
11 Jul 2011 |
Advaxis Completes Enrollment of Low Dose Cohort in CIN Study
|
|
11 Jul 2011 |
GlaxoSmithKline (GSK) Receives FDA Approval for BOOSTRIX to Help Prevent Whooping Cough in Adults 65 Years and Older
|
|
07 Jul 2011 |
Inovio Expands DNA Vaccine Intellectual Property License With the University of Pennsylvania
|
|
05 Jul 2011 |
Inovio Pharmaceuticals Synthetic DNA Vaccine Protects Against HIV in Non-Human Primates
|
|
04 Jul 2011 |
Sorrento Therapeutics' Innovative Approach to Developing Vaccines and Therapeutics for MRSA Receives Continued Support From the National Institute of Allergy and Infectious Diseases
|
|
30 Jun 2011 |
Scancell Develops New Vaccine for the Treatment of Lung Cancer
|
|
30 Jun 2011 |
Inovio Pharmaceuticals' DNA Vaccine for Foot-and-Mouth Disease Generates Protective Neutralizing Antibodies in Second Large-Animal Study
|
|
30 Jun 2011 |
Medicago reports positive Phase II final results for its avian flu pandemic vaccine
|
|
29 Jun 2011 |
Inovio Pharmaceuticals' Prostate Cancer DNA Vaccine Demonstrates Strong T Cell Responses in Monkeys; Company on Track for Phase I Clinical Trial
|
|
28 Jun 2011 |
VaxyGen Vaccines Ltd. Announces Exclusive Strategic Vaccine Collaboration with The Serum Institute of India (SII)
|
|
28 Jun 2011 |
Vical Provides Allovectin(R) and Herpes Simplex Vaccine Updates at BIO International Convention
|
|
28 Jun 2011 |
Diamyd Medical: Diamyd Presents Detailed Results of European Phase III Study
|
|
28 Jun 2011 |
Sinovac Commences Phase II Clinical Trial for EV71 Vaccine
|
|
27 Jun 2011 |
PharmAthene Achieves Anthrax Vaccine Program Milestone and Successfully Completes Technology Transfer
|
|
24 Jun 2011 |
Singapore Health Sciences Authority Approves Emergent BioSolutions Anthrax Vaccine, BioThrax
|
|
23 Jun 2011 |
GeoVax Initiates Third Site For Therapeutic Testing of Its HIV Vaccine
|
|
23 Jun 2011 |
Diamyd Medical: Diamyd Initiates Closure of US Phase III study
|
|
21 Jun 2011 |
Mayo Clinic Researchers Use Human Vaccine to Cure Prostate Cancer in Mice
|
|
21 Jun 2011 |
Hemispherx Biopharma's Ampligen(R) Tested in Combination With Experimental Vaccine From Leading Cancer Research Institute
|
|
21 Jun 2011 |
NanoBio Announces First Patients Vaccinated in Phase 1b Intranasal Influenza Vaccine Study
|
|
20 Jun 2011 |
Hib Vaccine TAK-816 Enters into the Phase III Clinical Trial in Japan
|
|
20 Jun 2011 |
FDA Approves Immunovaccine's Application for a Phase I/II Clinical Trial for an Ovarian Cancer Vaccine
|
|
16 Jun 2011 |
Novartis application for expanded Menveo(R) indication from 2 months of age accepted for review by FDA
|
